KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Current Assets (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Current Assets readings, the most recent being $13.7 billion for Q1 2026.

  • On a quarterly basis, Current Assets rose 18.93% to $13.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $13.7 billion, a 18.93% increase, with the full-year FY2025 number at $13.9 billion, up 11.11% from a year prior.
  • Current Assets hit $13.7 billion in Q1 2026 for Teva Pharmaceutical Industries, down from $13.9 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $13.9 billion in Q4 2025 to a low of $11.4 billion in Q3 2023.
  • Median Current Assets over the past 5 years was $12.3 billion (2024), compared with a mean of $12.3 billion.
  • Biggest five-year swings in Current Assets: decreased 7.63% in 2023 and later grew 18.93% in 2026.
  • Teva Pharmaceutical Industries' Current Assets stood at $12.1 billion in 2022, then increased by 3.6% to $12.5 billion in 2023, then rose by 0.54% to $12.6 billion in 2024, then increased by 11.11% to $13.9 billion in 2025, then dropped by 1.69% to $13.7 billion in 2026.
  • The last three reported values for Current Assets were $13.7 billion (Q1 2026), $13.9 billion (Q4 2025), and $12.7 billion (Q3 2025) per Business Quant data.